Open Account Now
Nephrocare IPO
Nephrocare Health Services Limited
Nephrocare IPO Details
he IPO comprises a Fresh Issue of equity shares aggregating up to Rs. 353.41 crores and an Offer for Sale (OFS) of up to 12,792,056 equity shares by existing shareholders.
Promoters participating in the OFS include Investcorp Private Equity Fund II, Healthcare Parent Limited, Edoras Investment Holdings Pte. Ltd., and Investcorp Growth Opportunity Fund.
The issue is managed by ICICI Securities, Ambit Private Limited, IIFL Capital Services, and Nomura Financial Advisory and Securities
The equity shares are proposed to be listed on both BSE and NSE, with ‘in-principle’ approvals to be received from both exchanges.
Nephrocare IPO Strengths
- Nephrocare (NephroPlus) is India's largest dialysis service provider in terms of the number of dialysis sessions performed and centers operated. As of FY2024, it operated 419 centers across 196 cities and 22 states/UTs .
- It has entered into long-term Public Private Partnerships (PPPs) and hospital tie-ups that provide visibility and stability of revenue. 190 of its centers are government partnerships .
- NephroPlus has also expanded internationally to the Philippines, Uzbekistan, and operated one center in Kenya, giving it a strategic edge over India-only players .
- The company uses proprietary platforms like CarePro for real-time clinical and operational data, improving service consistency and efficiency .
Nephrocare IPO Weaknesses
- 45.35% of its operational centers are under government partnerships. Any policy changes or non-renewal of PPP contracts may adversely affect operations.
- Operations are working capital intensive. The company depends heavily on timely reimbursements from government schemes and hospitals .
- Its international business operations expose it to currency fluctuations and regulatory risk in other jurisdictions .
- NephroPlus primarily focuses on dialysis and related services. Over-reliance on a single specialty makes it vulnerable to market or tech disruptions in nephrology care .
Nephrocare Revenue & Profit
4.43 | -0.12 |
5.75 | +0.35 |
7.70 | +0.67 |
10
8
6
4
2
0
Nephrocare IPO Dates
| Open Date | To be announced |
| Close Date | To be announced |
| Allotment Date | To be announced |
| Initiation of Refunds | Credit of Shares to Demat Account |
| To be announced | |
| Listing Date | To be announced |
Nephrocare IPO Lot Size
| Minimum Lot Size | To be announced |
| Maximum Lot Size | To be announced |
Seize the Opportunity! Apply for Nephrocare IPO
Free Demat Account Opening
Zero AMC Charges for First Year
Low DP Charges (Rs. 10 only)
Free IPO Report & Research
Nephrocare IPO Subscription Breakup
| QIBs | To be announced |
| Non Institutional Investors | To be announced |
| Retail Investors | To be announced |
How to Apply for Nephrocare IPO?
Step 1
First, you need to visit the IPO section on our website.
Step 2
Then, click on the 'IPO Listing' option to view the IPO.
Step 3
Open the Nephrocare Limited IPO by tapping on it.
Step 4
You will see an option to subscribe that you need to click on.
Step 5
Now that you can see the IPO details, you must enter details like cut-off price, number of lots, and UPI ID.
Step 6
Next, verify your details and select the 'Subscribe' option to complete the bidding.
You have completed your bidding for the Nephrocare Limited IPO. Log in and go to the 'IPO Transactions' section to track your allotment status.